Beginning July 20, Claude Fable 5 will be included in all Max and Team Premium plans, at 50% of limits.
Pro and Team Standard users will continue to have access to Fable via usage credits, and will receive a one-time $100 credit.
Demand for Fable has been challenging to predict, which is why we rolled it out to subscription plans in stages, extending access several times as we secured additional capacity.
The scary part about Anthorpic's Fable nerf is not that it refuses to answer biology or cryptography. It's that it foreshadows what's coming. A world where a couple companies decide what you can and cannot do. They're building a new ruling class and you're not in it...
@zhitzig@nytopinion Thanks for being so outspoken! I agree that we should begin talking about some form of public oversight over AI - not just for OpenAI, but AI in general.
The risk of manipulation is too high to leave AI in the hands of a small number of companies alone.
@burkov Guess every master or PhD student has a supervisor that normally functions as gatekeeper to let students only graduate if they've shown they understand? At least that's how it worked 20yrs ago...but maybe things changed
Rappel pour nos amis chercheurs et étudiants : il est INTERDIT d'utiliser ce site qui permet d'accéder à tous les articles de recherche gratuitement !
Ce site est souvent bloqué par les fournisseurs internet, il est aussi interdit de contourner le blocage avec cette méthode. 🧵
Once again the most widely downloaded GIS software on the planet is reduced to begging for funding, in an amount that would barely equip a small county office with the leading proprietary brand. Please give. 🙄
https://t.co/EsBmyx34wr
Drug resistant #TB is a serious public health problem in India.
@TheLancet published a game changing paper—and hid it behind a paywall—that shows 9-month regimen is as good as 24-month one.
Doctors who treat potentially fatal TB can’t read the paper.
Who's the paper for?
@lpachter When I was asked to review a paper on behalf of my PhD-/postdoc- supervisor, it's been a great opportunity to learn. If the professor makes the effort to review the review, it's a win-win for everyone: trainee learns, prof teaches, paper is reviewed
🔊Join the NGO Delegation for a webinar on the future of TB diagnostics
Tuesday 11 October from 2-3:30pm (CET)
You can register using the link below: https://t.co/7ftQpndizc
A diagnostic device in development could offer a way to identify COVID-19 infection, strain, and level of immunity without needing to send samples to a lab https://t.co/jCRLSb3bN5
Another great quote shared during today's trilateral workshop by Dr. Ongarello, @FINDdx. While talking about #vaccineaccess, also important to remember the #DiagnosticsGap
An impressive list of global health books (and related topics), put together by @paimadhu My personal favorite "We Crossed a Bridge and It Trembled: Voices from Syria" from @Wendy_Pearlman